Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Lyograft

K-Number: K192452 · 2020-09-03

ApplicantB. Bruan Surgical, SA
Decision Date2020-09-03
Product CodeFTM
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Lyograft is a medical device manufactured by B. Bruan Surgical, SA. It received FDA 510(k) clearance on 2020-09-03 under approval number K192452. The device is classified under product code FTM. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Lyograft?

Lyograft is a medical device that received FDA 510(k) clearance on 2020-09-03. It is manufactured by B. Bruan Surgical, SA. The 510(k) number is K192452.

When was Lyograft approved by the FDA?

Lyograft received FDA 510(k) clearance on 2020-09-03, under approval number K192452.

What company makes Lyograft?

Lyograft is manufactured by B. Bruan Surgical, SA.

What is the FDA product code for Lyograft?

The FDA product code for Lyograft is FTM.

Related Devices (Code: FTM)

K162461Endoform Plastics and Reconstructive MatrixAroa Biosurgery (Formerly Mesynthes Limited) K162554Gentrix Surgical MatrixAcell, Inc. K160181COLORADO THERAPEUTICS XENOGRAFT IMPLANTColorado Therapeutics, LLC K161221Biodesign Sling, Biodesign Plastic Surgery Matrix, Biodesign Anal Fistula PlugCook Biotech Incorporated K160869Biodesign Tissue Graft, Biodesign Dural Graft, Biodesign Peyronie's Repair GraftCook Biotech Incorporated K153633Endoform Reconstructive TemplateAroa Biosurgery Limited (Formerly Mesynthes Limited)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑